Showing results (281-290 of 319) with videos related to

Sort By:
Pageof 32
Annals of Neurology|October 1, 1990
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyD J Brooks, V Ibanez, G V Sawle, et al.
Brain Research. Molecular Brain Research|December 5, 1998
Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's diseaseD J Eve, A P Nisbet, A E Kingsbury, et al.
Brain : a Journal of Neurology|August 1, 1991
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal gangliaD T Dexter, A Carayon, F Javoy-Agid, et al.
Neurology|August 25, 2004
Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson diseaseR A Page, C A Davie, D MacManus, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 16, 1999
Unilateral pallidotomy for Parkinson's disease: results after more than 1 yearA Schrag, M Samuel, E Caputo, et al.
Brain : a Journal of Neurology|October 2, 2004
Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsyD C Paviour, A J Lees, K A Josephs, et al.
FEBS Letters|October 24, 1994
Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative diseaseJ P Spencer, A Jenner, O I Aruoma, et al.
Neuropathology and Applied Neurobiology|February 20, 2008
Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of diseaseT Lashley, T Revesz, G Plant, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1994
Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR studyD T Dexter, A E Holley, W D Flitter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1994
Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunctionT W Robbins, M James, A M Owen, et al.
Pageof 32